TRACEY BAKER: Open Payments
NPI 1508071515 · GRIFFIN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$302 in 16 payments from 4 companies in 2025. Trend: 2023 $41 · 2024 $149 · 2025 $302
Food & beverage: $302
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $157 |
| Novo Nordisk Inc | 6 | $115 |
| Elucent Medical | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: VRAYLAR, Wegovy, Ozempic, UBRELVY, QULIPTA, SHINGRIX.
Industry payments across GA — which companies pay providers there.
